semaglutide news oct 26 2025 The FDA has approved the first GLP-1 pill for weight loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular FBI issues safety warning about

The scientific paradox: conflicting evidence explained A genuine scientific paradox exists in the semaglutide blood clot data

Semaglutide Industry Developments June 2026 : Novo Nordisk presented Phase 3 results of its REIMAGINE 1-3 trials

GLP-1 Receptor Agonists: The Science Behind It Semaglutide is part of a group of medications known as GLP-1 receptor agonists

In her practice, the phenomenon wasn't really apparent until Ozempic hit the American market in 2018, and even then, she learned about it only from her patients

Potential Effects of GLP-1 Receptor Agonists on Salivary Glands and Oral Health

They begin in the tissues that support the testicles